|
Originally published In Press as doi:10.1074/jbc.M104979200 on August 30, 2001
J. Biol. Chem., Vol. 276, Issue 44, 40933-40939, November 2, 2001
Recovering Antibody Secretion Using a Hapten Ligand as a Chemical
Chaperone*
Gregory D.
Wiens §,
Thomas
O'Hare¶, and
Marvin B.
Rittenberg
From the Department of Molecular Microbiology and
Immunology and ¶ Department of Cell and Developmental Biology,
Oregon Health and Science University, Portland, Oregon 97201-3098
Engineered antibodies have come to the forefront
as research reagents and clinical therapeutics. However, reduced
stability or expression levels pose a major problem with many
engineered antibodies. As a model for understanding functional
consequences of variable region mutation, we have studied the assembly
and trafficking of anti-phenylphosphocholine antibodies. Previously, we
identified severe secretion defects because of mutations in the heavy
chain second complementarity determining region, which is involved in
antigen binding. Here we demonstrate that immunoglobulin secretion is
increased up to 27-fold by incubating stably transfected PCG1-1 cells
with cognate hapten p-nitrophenylphosphocholine. Secretion
was unaffected by nonbinding analogs. Radiotracer and metabolic
labeling experiments demonstrated specific cellular uptake of
p-nitrophenylphosphocholine and increased intracellular heavy and light chain assembly. Brefeldin A inhibited hapten-mediated immunoglobulin secretion but not assembly, indicating that assembly occurs early within the biosynthetic pathway. Recovery of secretion correlated with antigen binding capacity, suggesting that the rescue
mechanism involves stabilization of heavy and light chain variable
domains. This model system provides the first demonstration that
cognate ligands can increase intracellular assembly of functional anti-hapten antibody within mammalian cells and suggests that small
molecules of appropriate specificity and affinity acting as
chemical chaperones may find application for increasing or regulating
immunoglobulin expression.
*
This work was supported by a research award grant from the
Oregon Chapter of the American Cancer Society (to G. D. W.)
and by National Institutes of Health Grants AI-14985 and AI-26827 (to
M. B. R.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Molecular
Microbiology and Immunology, L220, Oregon Health and Sciences University, 3181 S.W. Sam Jackson Park Rd., Portland, OR 97201-3098. Tel.: 503-494-2096; Fax: 503-494-6862; E-mail:
wiensg@ohsu.edu.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Chih, S. K. Afridi, L. Clark, and P. Scheiffele
Disorder-associated mutations lead to functional inactivation of neuroligins
Hum. Mol. Genet.,
July 15, 2004;
13(14):
1471 - 1477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. Wiens, M. Brown, and M. B. Rittenberg
Repertoire Shift in the Humoral Response to Phosphocholine-Keyhole Limpet Hemocyanin: VH Somatic Mutation in Germinal Center B Cells Impairs T15 Ig Function
J. Immunol.,
May 15, 2003;
170(10):
5095 - 5102.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|